By Jim Welch, EY Global MedTech Leader, Health Sciences and Wellness On August 4, 2020, AdvaMed and EY hosted the first in a series of MedTech CEO roundtables bringing together senior leaders, many of whom are part of AdvaMed’s Accel …
by Gerry Bannister, FNP, Senior Advisor, IDNs, InterSystems Most MedTech companies are looking for the best approach to access, manage and leverage data – in an environment of ever-increasing data volume and complexity. What if you have a great idea …
By Brian Chapman “Do you want to share pulse information from your Garmin watch with Apple Health?” I don’t know… Maybe? Many of us have seen this type of message on our wearable devices and smartphones, and we’re often hesitant. …
by Rachel Shelly, Head of Medical Technologies and Healthcare Services, IDA Ireland A major challenge for medtech decision makers is selecting a digital strategy for international markets that considers scaling, deployment and the all-important aspect of data, a product’s value …
Keep ReadingDigital Health: Perspectives on Data, Partnerships and Scaling Internationally
Non-dilutive funding can play a key role in a life science organization’s financial strategy. The money available annually for extramural research from US government agencies is substantial; approximately $50 billion is budgeted for grants for various programs. Programs may be …
By Jon Speer, in Quality Management System (QMS) and EU MDR and Medical Device Quality Management System How prepared is your quality management system for the new requirements of EU MDR for medical devices that will go into effect in less than a year? The European …
Keep ReadingThe Essential Guide to Preparing Your QMS for EU MDR
By Doug Beveridge, Principal and Health Care Practice Leader at The Alexander Group This is an exciting time for health care. MedTech companies are expanding beyond traditional products and boundaries. Value is moving from a physical product to the information …
The Real World Evidence panel at The MedTech Conference will feature representation from the FDA, NEST and other industry representatives. Below, moderator Seth Goldenberg (vice president of medical devices and diagnostics at Veeva) and panelist Manish Bharara (senior manager of …
Keep ReadingReal-World Evidence: The need for continued dialogue across device stakeholders.
By Kolaleh Eskandanian, Ph.D., MBA, PMP, vice president and chief innovation officer at Children’s National Health System Are you interested in advancing device clinical trials in general, but also learning about potential innovative pathways for pediatrics? If yes, then make …
By Chris Rao, Director, Alira Health Clinical Planning a relevant and accurate budget, regardless of the trial phase or indication, can be one of the most challenging aspects of the clinical trial process. Though it is one of the most …
Keep ReadingFour Critical Factors for Clinical Trial Budget Success
